The present invention relates to an implantable paste comprising bioactive glass spheres having a size distribution of 50-425 µm, low molecular weight polyethylene glycol having a molecular weight range of 200-700 g/mol, and medium molecular weight polyethylene glycol having a molecular weight range of 700-2500 g/mol.